MITRA.BR
Price:
$0.216
Market Cap:
$14.93M
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In ad...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-30
Stock Exchange
EURONEXT
Ticker
MITRA.BR
According to Mithra Pharmaceuticals SA’s latest financial reports and current stock price. The company's current PE Ratio is -0.15. This represents a change of -87.98% compared to the average of -1.25 of the last 4 quarters.
The mean historical PE Ratio of Mithra Pharmaceuticals SA over the last ten years is -19.45. The current -0.15 PE Ratio has changed -22.90% with respect to the historical average. Over the past ten years (40 quarters), MITRA.BR's PE Ratio was at its highest in in the December 2019 quarter at 3.70. The PE Ratio was at its lowest in in the January 2012 quarter at -484.21.
Average
-19.45
Median
-8.79
Minimum
-62.89
Maximum
-0.50
Discovering the peaks and valleys of Mithra Pharmaceuticals SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 200.90%
Maximum Annual PE Ratio = -0.50
Minimum Annual Increase = -82.23%
Minimum Annual PE Ratio = -62.89
Year | PE Ratio | Change |
---|---|---|
2023 | -0.50 | -82.23% |
2022 | -2.80 | -62.26% |
2021 | -7.42 | -15.33% |
2020 | -8.77 | -76.50% |
2019 | -37.32 | 40.88% |
2018 | -26.49 | 200.90% |
2017 | -8.80 | 10.05% |
2016 | -8.00 | -74.64% |
2015 | -31.55 | -49.84% |
2014 | -62.89 | -73.67% |
The current PE Ratio of Mithra Pharmaceuticals SA (MITRA.BR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.57
5-year avg
-11.36
10-year avg
-19.45
Mithra Pharmaceuticals SA’s PE Ratio is greater than Biocartis Group NV (-0.32), greater than argenx SE (-157.17), less than Ontex Group NV (10.83), less than Melexis NV (14.88), less than Barco NV (19.02),
Company | PE Ratio | Market cap |
---|---|---|
-0.32 | $27.24M | |
-157.17 | $29.16B | |
10.83 | $709.23M | |
14.88 | $3.10B | |
19.02 | $1.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mithra Pharmaceuticals SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mithra Pharmaceuticals SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Mithra Pharmaceuticals SA's PE Ratio?
How is the PE Ratio calculated for Mithra Pharmaceuticals SA (MITRA.BR)?
What is the highest PE Ratio for Mithra Pharmaceuticals SA (MITRA.BR)?
What is the 3-year average PE Ratio for Mithra Pharmaceuticals SA (MITRA.BR)?
What is the 5-year average PE Ratio for Mithra Pharmaceuticals SA (MITRA.BR)?
How does the current PE Ratio for Mithra Pharmaceuticals SA (MITRA.BR) compare to its historical average?